CClinicalTrials.gg
CompletedNCT04525742Updated Nov 3, 2020

COVID-19 Pandemic and Parents of Disabled Children

An interventional study of Difficulties lived by disabled children's parents in the period of COVID-19 pandemic in COVID-19, Disabilities Multiple and Cerebral Palsy, sponsored by Gaziosmanpasa Research and Education Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-03.

Sponsored by Gaziosmanpasa Research and Education Hospital · Not applicable, Interventional, and Screening

Phase
Not applicable
Study type
Interventional
Enrollment
309
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Pandemic period could affect the disabled children's rehabilitation and follow-up negatively because of preventive measures and this could create adverse results on their parents.

In this research, it is aimed to determine the positive and negative effects of pandemic on parents and disabled children and to provide an insight for future solutions.

Read the detailed description

To determine the effect of COVID-19 pandemic and the possible difficulties experienced by the parents of disabled children, a questionnaire was prepared. It takes approximately 10-15 minutes to complete the survey. Questionnaire is loaded to qualtrics program and sent to the families by e-mail or social media accounts.

02

Conditions studied

  • COVID-19
  • Disabilities Multiple
  • Cerebral Palsy
  • Muscular Dystrophies

Keywords

  • cerebral palsy
  • COVID-19
  • pandemic
  • disability
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 309 is above the median of 100 across 4,098 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Gaziosmanpasa Research and Education Hospital is the lead sponsor of 122 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Having disabled child/children
  • Having ability and facility to use internet
  • Having ability to read and write
  • Having enough cognitive capacity to answer the questionnaire
  • To accept to participate the research

Exclusion criteria

Exclusion Criteria:

  • Not having disabled child/children
  • Not having ability and facility to use internet
  • Not having ability to read and write
  • Not having enough cognitive capacity to answer the questionnaire
  • Not to accept to participate the research
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
309 participants (actual)

Study arms

  • Other
    Parents who have a disabled child or children

    Parents having disabled child or children will be included in the research and it will be wanted to complete the survey questionary

    Other: Difficulties lived by disabled children's parents in the period of COVID-19 pandemic

Interventions

  • OtherDifficulties lived by disabled children's parents in the period of COVID-19 pandemic

    It will be a cross sectional study to obtain the information on difficulties lived by disabled children's parents during recent pandemic period

06

What researchers measure

Primary outcomes

  1. A questionnaire that we created will be used to determine the difficulties experienced by disabled children's parents during Covid 19 pandemic related to their medical follow-up

    Difficulties related to rehabilitation facilities, other medical conditions or ortosis could increase because of Covid 19 pandemic unique conditions

    Time frame: 4 weeks

Secondary outcomes

  1. The Fear of COVID-19 Scale

    The Fear of COVID-19 Scale, a seven-item scale, has robust psychometric properties. It is reliable and valid in assessing fear of COVID-19 among the general population and will also be useful in allaying COVID-19 fears among individuals. Score is minimum 7 pointts and maximum 35 points.

    Time frame: 4 weeks

07

Study locations

1 site
  • Health Science University Gaziosmanpasa Training and Research Hospital
    İstanbul, Gaziosmanpasa 34255, Turkey
08

References and documents

Publications

  • Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2022;20(3):1537-1545. doi: 10.1007/s11469-020-00270-8. Epub 2020 Mar 27. PubMed 32226353 ↗

Individual participant data

Plan to share: Yes — Study protocol was established by Berrin Huner and Ebru Yilmaz Yalcınkaya Statistical analysis (Power analysis) was established by Ozden Ozyemisci Taskiran Informed consent was written by Berrin Huner

Supporting information: Study protocol, Sap, Icf

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 3, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04525742
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Responsible party
Berrin Hüner (Medical Doctor, Gaziosmanpasa Research and Education Hospital) — Principal investigator
First posted
Aug 25, 2020
Start date
Jul 5, 2020
Primary completion
Aug 30, 2020
Completion
Sep 15, 2020
Last update
Nov 3, 2020

Study contacts

Resa Aydin, Professor
principal investigator · İstanbul University İstanbul Faculty of Medicine
Evrim Karadağ Saygı, Professor
principal investigator · Marmara University Faculty of Medicine
Özden Özyemisçi Taşkıran, Professor
principal investigator · Koc University Faculty of Medicine
Nalan Çapan, Professor
principal investigator · İstanbul University İstanbul Faculty of Medicine
Ebru Yilmaz Yalçınkaya, Professor
study director · Health Science University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion